%0 Journal Article
%T Corrigenda: Residual enhancing disease after surgery for glioblastoma: evaluation of practice in the United Kingdom
%J Archive of "Neuro-Oncology Practice".
%D 2018
%R 10.1093/nop/npy017
%X Erratum to Ma et al. Residual enhancing disease after surgery for glioblastoma: evaluation of practice in the United Kingdom. Neurooncol Pract (first published online 27 September 2017 doi:10.1093/nop/npx023
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656317/